| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/28/1997 | WO1997030582A1 Production of hydroxylated fatty acids in genetically modified plants |
| 08/28/1997 | WO1997030581A1 Male-sterile plants |
| 08/28/1997 | WO1997026523A3 Detection of a leptin receptor variant and methods for regulating obesity |
| 08/28/1997 | WO1997023612A3 Targeted compounds with cartilage formation-inducing and/or bone formation-inducing activity |
| 08/28/1997 | WO1997021822A3 Methods and compositions for synthesis of oligosaccharides using mutant glycosidase enzymes |
| 08/28/1997 | WO1997020935A3 Viral vectors |
| 08/28/1997 | WO1997020064A3 Process for assessing the activity of drugs |
| 08/28/1997 | WO1997020051A3 Vectors and methods for gene transfer to cells |
| 08/28/1997 | WO1997019180A3 Vector consisting of a transcriptional regulatory DNA sequence linked to a DNA sequence encoding beta-lactamase for enzyme prodrug therapy |
| 08/28/1997 | WO1997016535A3 Methods for use of mpl ligands with primitive human stem cells |
| 08/28/1997 | WO1997015676A3 Candida topoisomeraseigene |
| 08/28/1997 | DE19607367A1 Conjugate of ligand for low density lipoprotein receptor and nucleic acid carrier |
| 08/28/1997 | DE19607202A1 Separation of RNA and DNA from cells by treatment with lytic solution |
| 08/28/1997 | CA2247517A1 Modified nuclear glucocorticoid receptor, fusion protein, and dna fragments coding for said receptor and said fusion protein |
| 08/28/1997 | CA2247162A1 Production of proteins, plasmids coding therefor and organisms containing such plasmids |
| 08/28/1997 | CA2247106A1 Technique for representing combinatorial chemistry libraries resulting from selective combination of synthons |
| 08/28/1997 | CA2247068A1 Crystal structure of apopain and uses thereof |
| 08/28/1997 | CA2246359A1 Methods and compositions for protective and therapeutic genetic immunization |
| 08/28/1997 | CA2246300A1 Cell-based assay |
| 08/28/1997 | CA2246226A1 Rat ob receptors and nucleotides encoding them |
| 08/28/1997 | CA2245646A1 Synthetic hiv genes |
| 08/28/1997 | CA2242859A1 Production of hydroxylated fatty acids in genetically modified plants |
| 08/28/1997 | CA2241142A1 Liposomal-viral dna complexes for treating disease |
| 08/28/1997 | CA2216874A1 Method for changing composition of phospholipids produced by organism and recombinant vector therefor |
| 08/27/1997 | EP0791660A1 A novel diagnostic marker for splicing variants of genes associated with neurological function |
| 08/27/1997 | EP0791656A2 Platenolide synthase gene |
| 08/27/1997 | EP0791655A2 Polyketide synthase genes |
| 08/27/1997 | EP0791654A1 Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of Borna disease virus, nucleic acid fragments coding therefore and their use for diagnostic and immunization purposes |
| 08/27/1997 | EP0791653A1 Human Fc-gamma receptor III |
| 08/27/1997 | EP0791652A1 Transgenic mammals expressing polypeptide-containing substances in their milk |
| 08/27/1997 | EP0791359A1 Remedy for diseases caused by il-6 production |
| 08/27/1997 | EP0791079A2 Detection of human retrovirus infection |
| 08/27/1997 | EP0791078A1 Methods for drug screening |
| 08/27/1997 | EP0791077A1 Methods for modulating transcription from the amyloid beta-protein precursor (app) promoter |
| 08/27/1997 | EP0791076A1 Diagnostic method and kit for determining kell blood group genotype |
| 08/27/1997 | EP0791074A2 Method for the detection of ras oncogenes, in particular the k-ras ancogene |
| 08/27/1997 | EP0791068A1 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications |
| 08/27/1997 | EP0791067A2 Protein kinase npk-110 |
| 08/27/1997 | EP0791066A1 Dna molecules that code for enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing said molecules |
| 08/27/1997 | EP0791065A1 Protein targeting into hiv virions based on hiv-1 vpr fusion molecules |
| 08/27/1997 | EP0791064A1 Method for enhancing the immunogenicity of an immunogenic compound or hapten, and use thereof for preparing vaccines |
| 08/27/1997 | EP0791063A1 Carrier protein having an adjuvant effect, immunogenic complex containing same, preparation method therefor, nucleotide sequence and vaccine |
| 08/27/1997 | EP0791062A1 Dna which regulates gene expression in coryne-form bacteria |
| 08/27/1997 | EP0791061A1 Animals with targeted gene disruption |
| 08/27/1997 | EP0791060A2 Ribozyme analogs |
| 08/27/1997 | EP0791059A1 Production of recombinant peptides as natural hydrophobic peptide analogues |
| 08/27/1997 | EP0791058A1 Nucleotide sequence encoding the enzyme i-scei and the uses thereof |
| 08/27/1997 | EP0791057A1 Method of preparing oligonucleotide probes or primers, vector therefor and use thereof |
| 08/27/1997 | EP0791052A1 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 08/27/1997 | EP0791051A1 Neural cultures |
| 08/27/1997 | EP0791050A1 Vectors for tissue-specific replication |
| 08/27/1997 | EP0791013A2 Methods and compositions for screening for presynaptic calcium channel blockers |
| 08/27/1997 | EP0791010A1 Retroviral vectors containing recombinant cmv-ie/hiv-tar/moloney murine leukemia virus long terminal repeats |
| 08/27/1997 | EP0791009A1 Modified neuropeptide y receptors |
| 08/27/1997 | EP0791008A1 Screen for compounds with affinity for rna |
| 08/27/1997 | EP0790965A1 Synthesis of ?35 s-labeled oligonucleotides with 3h-1,2-benzodithiol-3-1,1-dioxide |
| 08/27/1997 | EP0790861A1 Device and method for dna amplification and assay |
| 08/27/1997 | EP0790835A1 Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector |
| 08/27/1997 | EP0790833A1 Process for identifying para cation channel modulators |
| 08/27/1997 | EP0790830A1 Trophinin and trophinin-assisting proteins |
| 08/27/1997 | EP0745090B1 Oligonucleotides with anti-respiratory syncytial virus activity |
| 08/27/1997 | EP0701624B1 Method for the determination of salmonella |
| 08/27/1997 | EP0700437B1 Dna encoding prostaglandin receptor ep1 |
| 08/27/1997 | EP0637966B1 Bystander effect tumoricidal therapy |
| 08/27/1997 | EP0600901B1 Anti-hirudin polyclonal antibodies and their use for the identification, immunopurification and quantitative determination of hirudin |
| 08/27/1997 | EP0527724B1 Compositions and treatments for pneumonia in animals |
| 08/27/1997 | EP0524205B1 Live vaccines |
| 08/27/1997 | CN1158144A Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 08/27/1997 | CN1158134A Antibodies which activate an erythropoietin receptor |
| 08/27/1997 | CN1157924A Holder assembly for reaction tubes |
| 08/27/1997 | CN1157828A Truncated form of inhibitory kappa B protein (IKB) recombinant production and uses thereof |
| 08/27/1997 | CN1157827A Novel, ATP-sensitive potassium-channel proteins and genes for the same |
| 08/27/1997 | CN1157826A Novel, ubiquitous potassium-channel proteins and genes for the same |
| 08/26/1997 | US5661135 Human VEGF-specific oligonucleotides |
| 08/26/1997 | US5661134 Oligonucleotides for modulating Ha-ras or Ki-ras having phosphorothioate linkages of high chiral purity |
| 08/26/1997 | US5661133 Injecting expression vector containing dna segment encoding selected gene into myocardium of mammalian host; obtaining expression in cardiac myocytes of protein encoded by said gene |
| 08/26/1997 | US5661033 Gene transfer using herpes virus vectors as a tool for neuroprotection |
| 08/26/1997 | US5661032 Controller of transcription of marker gene |
| 08/26/1997 | US5661028 Miniaturized substrate having etched microchannels partially filled with gel and covered with clear plate; concurrent dna sequencing |
| 08/26/1997 | US5661026 Used for controlling biopolymer synthesis by determining the genetics and enzymology of polyhydroxybutyrate biosynthesis at the molecular level |
| 08/26/1997 | US5661025 Self-assembling polynucleotide delivery system comprising dendrimer polycations |
| 08/26/1997 | US5661022 Purification of retroviral vectors |
| 08/26/1997 | US5661021 Mannanase enzymes, genes coding for them and a method for isolating the genes, as well as a process for bleaching of lignocellulosic pulp |
| 08/26/1997 | US5661018 Phosphatidylcholine for lipofection as carrier treating gene disorder |
| 08/26/1997 | US5661017 Introducing recombinant nucleic acid molecule encoding dominant selectable marker linked to algal regulatory control sequence into chlorophyll c containing alga so that marker is produced by transformed alga |
| 08/26/1997 | US5661016 Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| 08/26/1997 | US5661015 Recombinant coccidiosis vaccines |
| 08/26/1997 | US5661012 Method for the production of L-threonine by fermentation, using mutated DNA encoding aspartokinase III |
| 08/26/1997 | US5661011 Sexing method of bovine embryos |
| 08/26/1997 | US5661009 Providing host cell transformed with dna encoding a consensus human leukocyte interferon, culturing cell to effect expression of dna |
| 08/26/1997 | US5661007 Culturing; recovering; purification; administering to induce bone and/or cartilage formation |
| 08/26/1997 | US5661006 Polynucleotides genetic engineering a vaccines |
| 08/26/1997 | US5661005 Purified, isolated single-stranded dna sequence; culture product |
| 08/26/1997 | US5661004 Lymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof |
| 08/26/1997 | US5661003 Dna encoding vasopressin-regulated water channel protein localized in kidney collecting tubule |
| 08/26/1997 | US5661002 Modified transcription control unit and uses thereof |
| 08/26/1997 | US5661001 High molecular weight desulphatohirudin |
| 08/26/1997 | US5660999 P0438, a new calcium-regulated promoter |
| 08/26/1997 | US5660986 Immortalized human cell lines containing exogenous cytochrome P450 genes |
| 08/26/1997 | US5660985 Contacting mixture of modified single-stranded nucleic acids with target molecule, partitioning those with increased affinity, amplifying to identify ligands of target molecule |